Factor V/Va-targeting MAb GB-5 promotes thrombus formation in vivo for treating bleeding disorders Dec. 17, 2021
STAR-0215, a potent and long-acting MAb plasma kallikrein inhibitor for the treatment of HAE Nov. 8, 2021
New AAV/CRISPR strategy corrects complex genetic defects in a severe hemophilia B model Oct. 29, 2021
RSS